期刊
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
卷 14, 期 6, 页码 745-756出版社
BENTHAM SCIENCE PUBL
DOI: 10.2174/1871527314666150529144655
关键词
Accumbens; addiction; ceftriaxone; excitatory amino acid transporter 2; glutamate transport; glutamate transporter 1; glutamate; N-acetylcysteine
资金
- NIH [TR000061, GM008716, DA038893, DA 03906-31, DA015369-11]
The development of new treatments for substance use disorders requires identification of targetable molecular mechanisms. Pathology in glutamatergic neurotransmission system in brain reward circuitry has been implicated in relapse to multiple classes of drugs. Glutamate transporter 1 (GLT-1) crucially regulates glutamatergic signaling by removing excess glutamate from the extrasynaptic space. The purpose of this review is to highlight the effects of addictive drug use on GLT-1 and glutamate uptake, and using GLT-1 as a target in addiction pharmacotherapy. Cocaine, opioids, ethanol, nicotine, amphetamines, and cannabinoids each affect GLT-1 expression and glutamate uptake, and restoring GLT-1 expression with N-acetylcysteine or ceftriaxone shows promise in correcting pre-clinical and clinical manifestations of drug addiction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据